It is often noticed that investors are increasingly prone to look into those stocks which may have clocked considerable gains over a reasonable period of time and hence, it may be a good time to look into the ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) (IPA.V) stock.
The stock has been in the middle of a major rally in recent weeks and over the course of the past month, it has managed to bring in gains to the tune of as much as 40%. In light of such gains, it may be a good time for investors to take a closer look at some recent events. Back on April 14, the company was actually in the news after it announced that it had been successful in picking up a controlling stake in the trio of Belgian biotech firms BioKey BV, BioClue BV and BioStrand BV.
In this regard, it is necessary to point out that the three entities are now going to be known collectively as BioStrand. The entities are involved in the biotechnology and bioinformatics spaces and the acquisition was completed by IPA through its fully owned subsidiary company ImmunoPrecise Netherlands BV. It was a major new acquisition for the company and one that could lead to a considerable long-term boost for IPA as a company.
The Chief Executive Officer of IPA, Dr. Jennifer Bath spoke about the deal as well. She noted that the acquisition of BioStrand is another proof of IPA’s commitment to the acquisition of technologies that could be transformative.
She went on to add that the personnel at IPA have worked on the possibility of using machine learning and artificial intelligence technologies for bringing about transformative results. It is now going to be interesting to see if the stock can manage to hold on to its momentum and add to its gains this week.
